Mitochondrial free radical signal in ceramide-dependent apoptosis: A putative mechanism for neuronal death in Parkinson's disease

Journal of Neurochemistry

Volumn 69, Issue 4, 1997, Pages 1612-1621

  France Lanord, Valentine ^a   Brugg, Bernard ^a   Michel, Patrick P ^a   Agid, Yves ^a   Ruberg, Merle ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Free radicals; Nuclear factor B; Oxidative stress; PC12 cells; Sphingomyelin pathway; Superoxide

Indexed keywords

CERAMIDE; FREE RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; SPHINGOMYELIN; SUPEROXIDE; TRANSCRIPTION FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ELECTRON TRANSPORT; HUMAN; HUMAN TISSUE; MITOCHONDRION; NERVE CELL MEMBRANE POTENTIAL; NERVE CELL NECROSIS; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0030885945     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69041612.x     Document Type: Article

References (69)

1. Anglade P., Vyas S., Javoy-Agid F., Herrero M. T., Michel P. P., Marquez J., Mouatt-Prigent A., Ruberg M., Hirsch E. C., and Agid Y. (1997) Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol. 12, 25-31.
2. Bauerle P. A. and Henkel T. (1994) Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12, 141-179.
3. Beal M. F. (1995) Mitochondrial Function and Oxidative Damage in Neurodegenerative Diseases. R. G. Landes, Austin, Texas.
4. Boka G., Anglade P., Wallach D., Javoy-Agid F., Agid Y., and Hirsch E. C. (1994) Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci. Lett. 172, 151-154.
5. Brugg B., Michel P. P., Agid Y., and Ruberg M. (1996) Ceramide induces apoptosis in cultured mesencephalic neurons. J. Neurochem. 66, 733-739.
6. Cleeter M. W. J., Cooper J. M., and Schapira A. H. V. (1992) Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement. J. Neurochem. 58, 786-789.
7. Damier P., Hirsch E. C., Zhang P., Agid Y., and Javoy-Agid F. (1993) Glutathione peroxidase, glial cells and Parkinson's disease. Neuroscience 52, 1-6.
8. Deckwerth T. H. and Johnson E. M. (1993) Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of NGF. J. Cell Biol. 123, 1207-1222.
9. Dexter D. T., Carter C. J., Wells F. R., Javoy-Agid F., Agid Y., Lees A., Jenner P., and Marsden C. D. (1989a) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52, 381-389.
10. Dexter D. T., Wells F. R., Lees A., Agid F., Agid Y., Jenner P., and Marsden C. D. (1989b) Increased nigral iron content and alteration in other metal ions occurring in brain in Parkinson's disease. J Neurochem. 52, 1830-1836.
11. Dexter D. T., Ward R. J., Wells F. R., Daniel S. E., Lees A. J., Peters T. J., Jenner P., and Marsden C. D. (1992) Alpha-tocopherol levels in brain are not altered in Parkinson's disease. Ann. Neurol. 32, 591-593.
12. Dexter D. T., Holley A. E., Flitter W. D., Slater T. F., Wells F. R., Daniel S. E., Lees A. J., Jenner P., and Marsden C. D. (1994) Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study. Mov. Disord. 9, 92-97.
13. Dugan L. L., Sensi S. L., Canzoniero L. M. T., Handran S. D., Rothman S. D., Lin T. S., Goldberg M. P., and Choi D. W. (1995) Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J. Neurosci. 15, 6377-6388.
14. Fahn S. and Cohen G. (1992) The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol. 32, 804-812.
15. Fernandez-Calle P., Molina J. A., Jiménez-Jiménez F. J., Vazquez A., Pondal M., Garcia-Ruiz P. J., Urra D. G., Domingo J., and Codoceo R. (1992) Serum levels of alpha-tocopherol (vitamin E) in Parkinson's disease. Neurology 42, 1064-1066.
16. German D. C., Manaye K. F., Sonsalla P. K., and Brooks B. A. (1992) Midbrain dopaminergic cell loss in Parkinson's disease and MPTP induced parkinsonism: sparing of calbindin-D28K containing cells. Ann. NY Acad. Sci. 648, 42-62.
17. Goossens V., Grooten J., DeVos K., and Fiers W. (1995) Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc. Natl. Acad. Sci. USA 92, 8115-8119.
18. Graham D. G. (1979) On the origin and significance of neuromelanin. Arch. Pathol. Lab. Med. 103, 359-362.
19. Greene L. A. and Tischler A. S. (1976) Establishment of a nor-adrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 73, 2424-2428.
20. Greenlund L. J. S., Deckwerth T. L., and Johnson E. M. Jr. (1995) Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 14, 303-315.
21. Gunasekar P. G., Kanthasamy A. G., Borowitz J. L., and Isom G. E. (1995) NMDA receptor activation produces concurrent generation of nitric oxide and reactive oxygen species: implication for cell death. J. Neurochem. 65, 2016-2021.
22. Halliwell B. (1992) Reactive oxygen species and the central nervous system, in Free Radicals in the Brain (Packer L. L., Prilipko L., and Christen Y., eds), pp. 21-40. Springer Verlag, Berlin.
23. Hannun Y. A. and Obeid L. M. (1995) Ceramide: an intracellular signal for apoptosis. Trends Biol. Sci. 20, 73-77.
24. Kennet T., Richter C., and Peterhans E. (1993) Tumor necrosis factor-a induces superoxide anion generation in mitochondria of L929 cells. Biochem. J. 289, 587-592.
25. Hirsch E. C. (1993) Does oxidative stress participate in nerve cell death in Parkinson's disease. Eur. Neurol. Suppl. 1, 52-59.
26. Hirsch E. C., Graybiel A. M., and Agid Y. (1988) Melanized dopaminergic neurons are differentially affected in Parkinson's disease. Nature 334, 345-348.
27. Hirsch E. C., Brandel J. P., Galle P., Javoy-Agid F., and Agid Y. (1991) Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an x-ray microanalysis. J. Neurochem. 56, 446-451.
28. Hirsch E. C., Mouatt A., Thomasset M., Javoy-Agid F., Agid Y., and Graybiel A. M. (1992) Expression of calbindin D28K-like immunoreactivity in catecholaminergic cell groups of the human midbrain: normal distribution and distribution in Parkinson's disease. Neurodegeneration 1, 83-93.
29. Hockenbery D. M., Oltvai Z., Yin X. M., Milliman C. L., and Korsmeyer S. J. (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241-251.
30. Hunot S., Brugg B., Ricard D., Michel P. P., Muriel M.-P., Ruberg M., Faucheux B. A., Agid Y., and Hirsch E. C. (1997) Nuclear translocation of NF-κB is increased in dopaminergic neurons of patients with Parkinson disease. Proc. Natl. Acad. Sci. USA 94, 7531-7536.
31. Janetsky B., Hauck S., Youdim M. B. H., Riederer P., Jellinger K., Pantucek F., Zöchling R., Boissl K. W., and Reichmann H. (1994) Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease. Neurosci. Lett. 169, 126-128.
32. Ji L., Shang G., Uematsu S., Akahori Y., and Hirabayashi Y. (1995) Induction of apoptotic DNA fragmentation and cell death by natural ceramide. FEBS Lett. 358, 211-214.
33. Johnson L. V., Walsh M. L., and Chen L. B. (1980) Localization of mitochondria in living cells with rhodamine 123. Proc. Natl. Acad. Sci. USA 77, 990-994.
34. Kerr J. F. R. and Harmon B. V. (1991) Definition and incidence of apoptosis. An historical perspective, in Apoptosis: The Molecular Basis of Cell Death (Tomei L. D. and Cope F. O., eds), pp. 5-29. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
35. Kish S. J., Morito C., and Hornykiewicz O. (1985) Glutathione peroxidase activity in Parkinson's disease brain. Neurosci. Lett. 58, 343-346.
36. Kolesnick R. and Golde D. W. (1994) The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signalling. Cell 77, 325-328.
37. Kolesnick R. N., Haimowitz-Friedman A., and Fuks Z. (1994) The sphingomyelin signal transduction pathway mediates apoptosis for tumor necrosis factor, Fas, and ionizing radiation. Biochem. Cell Biol. 72, 471-474.
38. Lafon-Cazal M., Pietri S., Culcasi M., and Bockaert J. (1993) NMDA-dependent superoxide production and neurotoxicity. Nature 364, 535-537.
39. Maftah A., Petit J. M., Ratinaud M., and Julian R. (1989) 10-Nonylacridine orange: a fluorescent probe which stains mitochondria independently of their energetic state. Biochem. Biophys. Res. Commun. 164, 185-190.
40. Marsden C. D. (1983) Neuromelanin and Parkinson's disease. J. Neural. Transm. Suppl. 19, 121-141.
41. Marttila R. J., Lorentz H., and Rinne U. K. (1988) Oxygen toxicity protecting enzymes in Parkinson's disease: increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus. J. Neurol. Sci. 86, 321-331.
42. 2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J. Neurochem. 65, 1740-1751.
43. Michel P. P., Vyas S., and Agid Y. (1992) Toxic effects of iron for cultured mesencephalic dopaminergic neurons derived from rat embryonic brains. J. Neurochem. 59, 118-127.
44. Michel P. P., Vyas S., and Agid Y. (1995) Synergistic differentiation by chronic exposure to cyclic AMP and nerve growth factor renders rat phaeochromocytoma PC12 cells totally dependent upon trophic support for survival. Eur. J. Neurosci. 7, 251-260.
45. Mochizuki H., Goto K., Mon H., and Mizuno Y. (1996) Histochemical detection of apoptosis in Parkinson's disease. J. Neurol. Sci. 137, 120-123.
46. Obeid L. M., Linardic C. M., Karolak L. A., and Hannun Y. A. (1993) Programmed cell death induced by ceramide. Science 259, 1769-1771.
47. Perry T. L., Godin D. V., and Hansen S. (1982) Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci. Lett. 33, 305-310.
48. Reynolds I. J. and Hastings T. G. (1995) Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J. Neurosci. 15, 3318-3327.
49. Richter C., Park J. W., and Ames B. N. (1988) Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc. Natl. Acad. Sci. USA 85, 6465-6467.
50. Riederer P., Sofic E., Rausch W.-D., Schmidt B., Reynolds G. P., Jellinger K., and Youdim M. B. H. (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem. 52, 515-520.
51. Ruberg M., France-Lanord V., Brugg B., Hunot S., Anglade P., Damier P., Faucheux B., and Agid Y. (1997a) Parkinson's disease, apoptosis and oxidative stress, in Oxidative Stress and Redox Regulation (Montagnier L., Olivier R., and Pasquier C., eds), pp. 473-487. Marcel Dekker, New York.
52. Ruberg M., Brugg B., Prigent A., Hirsch E., Brice A., and Agid Y. (1997b) Is differential regulation of mitochondrial transcripts in Parkinson's disease related to apoptosis? J. Neurochem. 68, 2098-2110.
53. Saggu H., Cooksey J., Dexter D., Wells F. R., Lees A., Jenner P., and Marsden C. D. (1989) A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J. Neurochem. 53, 692-697.
54. Schapira A. H. V. (1995) Nuclear and mitochondrial genetics in Parkinson's disease. J. Med. Genet. 32, 411-415.
55. Schapira A. H. V., Cooper J. M., Dexter D., Clark J. B., Jenner P., and Marsden C. D. (1990) Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54, 823-827.
56. Schulz J. B., Weller M., and Klockgether T. (1996) Potassium deprivation-induced apoptosis of cerebellar granule neurons: a sequential requirement for new mRNA and protein synthesis, ICE-like protease activity, and reactive oxygen species. J. Neurosci. 16, 4696-4706.
57. Schulze-Osthoff K., Bakker A. C., Vanhaesebroeck B., Beyaert R., Jacobs W. A., and Fiefs W. (1992) Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. J. Biol. Chem. 267, 5317-5323.
58. Schulze-Osthoff K., Bakker A. C., Vanhaesebroeck B., Beyaert R., Jacobs W. A., and Fiefs W. (1993) Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J. 12, 3095-3104.
59. Schwarz M. A., Lazo J. S., Yalowich J. C., Reynolds I., Kagan V. E., and Pitt B. R. (1994) Cytoplasmic metallothionein overexpression protects NIH 3T3 cells from tert-butyl hydroperoxide toxicity. J. Biol. Chem. 269, 15238-15243.
60. Sian J., Dexter D. T., Lees A. J., Daniel S., Agid Y., Javoy-Agid F., Jenner P., and Marsden C. D. (1994) Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36, 348-355.
61. Sofic E., Paulus W., Jellinger K., Riederer P., and Youdim M. B. H. (1991) Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J. Neurochem. 56, 978-982.
62. Talley A. K., Dewhurst S., Perry S. W., Dollard S. C., Gummuluru S., Fine S. M., New D., Epstein L. G., Gendelman H. E., and Gelbard H. A. (1995) Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA. Mol. Cell. Biol. 15, 2359-2366.
63. Tomkins M. M., Basgill E. J., Zamrini E., and Hill W. D. (1997) Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. Am. J. Pathol. 150, 119-131.
64. Troy C. M., Derossi D., Prochiantz A., Greene L. A., and Shelanski M. L. (1996) Downregulation of Cu/Zn superoxide dismutase leads to cell death via the nitric oxide-peroxynitrite pathway. J. Neurosci. 16, 253-261.
65. Vayssière J. L., Petit P. X., Risler Y., and Mignotte B. (1994) Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in cell lines conditionally immortalized with simian virus 40. Proc. Nail. Acad. Sci. USA 91, 11752-11756.
66. Yamada T., McGeer P. L., Baimbridge K. G., and McGeer P. (1990) Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin D28K. Brain Res. 52, 303-307.
67. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E. R., and Mizuno Y. (1996) Immunohistochemical detection of 4-hydroxynoneal protein adducts in Parkinson disease. Proc. Natl. Acad. Sci. USA 93, 2696-2701.
68. Zamzami N., Marchetti P., Castedo M., Decaudin D., Macho A., Hirsch T., Susin S. A., Petit P., Mignotte B., and Kroemer G. (1995) Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182, 367-377.
69. Zhang Y., Marcillat O., Giulivi C., Ernster L., and Davies K. J. A. (1990) The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J. Biol. Chem. 265, 16330-16336.